Manaksia Coated Metals & Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: December 9, 2025, 4:57 pm

Competitors of Manaksia Coated Metals & Industries Ltd

All Competitor Stocks of Manaksia Coated Metals & Industries Ltd

Quarterly Result

Last Updated: August 1, 2025, 5:30 pm

Below is a detailed analysis of the quarterly data for Manaksia Coated Metals & Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 250.00 Cr.. The value appears strong and on an upward trend. It has increased from 208.00 Cr. (Mar 2025) to 250.00 Cr., marking an increase of 42.00 Cr..
• For Expenses, as of Jun 2025, the value is 225.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 193.00 Cr. (Mar 2025) to 225.00 Cr., marking an increase of 32.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 24.00 Cr.. The value appears strong and on an upward trend. It has increased from 15.00 Cr. (Mar 2025) to 24.00 Cr., marking an increase of 9.00 Cr..
• For OPM %, as of Jun 2025, the value is 10.00%. The value appears strong and on an upward trend. It has increased from 7.00% (Mar 2025) to 10.00%, marking an increase of 3.00%.
• For Other Income, as of Jun 2025, the value is 4.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Mar 2025) to 4.00 Cr., marking an increase of 2.00 Cr..
• For Interest, as of Jun 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 8.00 Cr..
• For Depreciation, as of Jun 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 19.00 Cr.. The value appears strong and on an upward trend. It has increased from 7.00 Cr. (Mar 2025) to 19.00 Cr., marking an increase of 12.00 Cr..
• For Tax %, as of Jun 2025, the value is 25.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 25.00%.
• For Net Profit, as of Jun 2025, the value is 14.00 Cr.. The value appears strong and on an upward trend. It has increased from 5.00 Cr. (Mar 2025) to 14.00 Cr., marking an increase of 9.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.41. The value appears strong and on an upward trend. It has increased from 0.63 (Mar 2025) to 1.41, marking an increase of 0.78.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 4:53 am

Balance Sheet

Last Updated: December 4, 2025, 1:37 am

Below is a detailed analysis of the balance sheet data for Manaksia Coated Metals & Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2025) to 11.00 Cr., marking an increase of 3.00 Cr..
• For Reserves, as of Sep 2025, the value is 324.00 Cr.. The value appears strong and on an upward trend. It has increased from 219.00 Cr. (Mar 2025) to 324.00 Cr., marking an increase of 105.00 Cr..
• For Borrowings, as of Sep 2025, the value is 103.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 145.00 Cr. (Mar 2025) to 103.00 Cr., marking a decrease of 42.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 308.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 275.00 Cr. (Mar 2025) to 308.00 Cr., marking an increase of 33.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 746.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 646.00 Cr. (Mar 2025) to 746.00 Cr., marking an increase of 100.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 109.00 Cr.. The value appears to be declining and may need further review. It has decreased from 112.00 Cr. (Mar 2025) to 109.00 Cr., marking a decrease of 3.00 Cr..
• For CWIP, as of Sep 2025, the value is 80.00 Cr.. The value appears strong and on an upward trend. It has increased from 68.00 Cr. (Mar 2025) to 80.00 Cr., marking an increase of 12.00 Cr..
• For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Other Assets, as of Sep 2025, the value is 557.00 Cr.. The value appears strong and on an upward trend. It has increased from 465.00 Cr. (Mar 2025) to 557.00 Cr., marking an increase of 92.00 Cr..
• For Total Assets, as of Sep 2025, the value is 746.00 Cr.. The value appears strong and on an upward trend. It has increased from 646.00 Cr. (Mar 2025) to 746.00 Cr., marking an increase of 100.00 Cr..

Notably, the Reserves (324.00 Cr.) exceed the Borrowings (103.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Manaksia Coated Metals & Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 1.94. This value is below the healthy minimum of 5. It has increased from 1.51 (Mar 24) to 1.94, marking an increase of 0.43.
• For Diluted EPS (Rs.), as of Mar 25, the value is 1.94. This value is below the healthy minimum of 5. It has increased from 1.51 (Mar 24) to 1.94, marking an increase of 0.43.
• For Cash EPS (Rs.), as of Mar 25, the value is 3.08. This value is within the healthy range. It has increased from 2.75 (Mar 24) to 3.08, marking an increase of 0.33.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 28.53. It has increased from 20.52 (Mar 24) to 28.53, marking an increase of 8.01.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 28.53. It has increased from 20.52 (Mar 24) to 28.53, marking an increase of 8.01.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 98.36. It has decreased from 99.59 (Mar 24) to 98.36, marking a decrease of 1.23.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 7.93. This value is within the healthy range. It has increased from 7.66 (Mar 24) to 7.93, marking an increase of 0.27.
• For PBIT / Share (Rs.), as of Mar 25, the value is 6.78. This value is within the healthy range. It has increased from 6.42 (Mar 24) to 6.78, marking an increase of 0.36.
• For PBT / Share (Rs.), as of Mar 25, the value is 2.59. This value is within the healthy range. It has increased from 2.01 (Mar 24) to 2.59, marking an increase of 0.58.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 1.94. This value is below the healthy minimum of 2. It has increased from 1.51 (Mar 24) to 1.94, marking an increase of 0.43.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 1.94. This value is below the healthy minimum of 2. It has increased from 1.51 (Mar 24) to 1.94, marking an increase of 0.43.
• For PBDIT Margin (%), as of Mar 25, the value is 8.06. This value is below the healthy minimum of 10. It has increased from 7.68 (Mar 24) to 8.06, marking an increase of 0.38.
• For PBIT Margin (%), as of Mar 25, the value is 6.89. This value is below the healthy minimum of 10. It has increased from 6.44 (Mar 24) to 6.89, marking an increase of 0.45.
• For PBT Margin (%), as of Mar 25, the value is 2.63. This value is below the healthy minimum of 10. It has increased from 2.01 (Mar 24) to 2.63, marking an increase of 0.62.
• For Net Profit Margin (%), as of Mar 25, the value is 1.96. This value is below the healthy minimum of 5. It has increased from 1.51 (Mar 24) to 1.96, marking an increase of 0.45.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.96. This value is below the healthy minimum of 8. It has increased from 1.51 (Mar 24) to 1.96, marking an increase of 0.45.
• For Return on Networth / Equity (%), as of Mar 25, the value is 6.78. This value is below the healthy minimum of 15. It has decreased from 7.37 (Mar 24) to 6.78, marking a decrease of 0.59.
• For Return on Capital Employeed (%), as of Mar 25, the value is 17.30. This value is within the healthy range. It has decreased from 20.47 (Mar 24) to 17.30, marking a decrease of 3.17.
• For Return On Assets (%), as of Mar 25, the value is 2.38. This value is below the healthy minimum of 5. It has increased from 2.09 (Mar 24) to 2.38, marking an increase of 0.29.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.29. This value is within the healthy range. It has decreased from 0.39 (Mar 24) to 0.29, marking a decrease of 0.10.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.62. This value is within the healthy range. It has decreased from 1.17 (Mar 24) to 0.62, marking a decrease of 0.55.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.32. It has decreased from 1.36 (Mar 24) to 1.32, marking a decrease of 0.04.
• For Current Ratio (X), as of Mar 25, the value is 1.39. This value is below the healthy minimum of 1.5. It has increased from 1.21 (Mar 24) to 1.39, marking an increase of 0.18.
• For Quick Ratio (X), as of Mar 25, the value is 0.52. This value is below the healthy minimum of 1. It has increased from 0.44 (Mar 24) to 0.52, marking an increase of 0.08.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.02. This value is below the healthy minimum of 4. It has increased from 2.35 (Mar 24) to 3.02, marking an increase of 0.67.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 1.74 (Mar 24) to 0.00, marking a decrease of 1.74.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 0.96 (Mar 24) to 0.00, marking a decrease of 0.96.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 98.26 (Mar 24) to 0.00, marking a decrease of 98.26.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 99.04 (Mar 24) to 0.00, marking a decrease of 99.04.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 1.89. This value is below the healthy minimum of 3. It has increased from 1.74 (Mar 24) to 1.89, marking an increase of 0.15.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.46. This value is below the healthy minimum of 3. It has increased from 1.34 (Mar 24) to 1.46, marking an increase of 0.12.
• For Enterprise Value (Cr.), as of Mar 25, the value is 740.59. It has increased from 378.62 (Mar 24) to 740.59, marking an increase of 361.97.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.94. This value is below the healthy minimum of 1. It has increased from 0.51 (Mar 24) to 0.94, marking an increase of 0.43.
• For EV / EBITDA (X), as of Mar 25, the value is 11.75. This value is within the healthy range. It has increased from 6.66 (Mar 24) to 11.75, marking an increase of 5.09.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.79. This value is below the healthy minimum of 1. It has increased from 0.30 (Mar 24) to 0.79, marking an increase of 0.49.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 98.25 (Mar 24) to 0.00, marking a decrease of 98.25.
• For Price / BV (X), as of Mar 25, the value is 2.75. This value is within the healthy range. It has increased from 1.46 (Mar 24) to 2.75, marking an increase of 1.29.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.79. This value is below the healthy minimum of 1. It has increased from 0.30 (Mar 24) to 0.79, marking an increase of 0.49.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.05 (Mar 24) to 0.02, marking a decrease of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness